Cargando…

Evidence of aquaporin involvement in human central pontine myelinolysis

BACKGROUND: Central pontine myelinolysis (CPM) is a demyelinating disorder of the central basis pontis that is often associated with osmotic stress. The aquaporin water channels (AQPs) have been pathogenically implicated because serum osmolarity changes redistribute water and osmolytes among various...

Descripción completa

Detalles Bibliográficos
Autores principales: Popescu, Bogdan F Gh, Bunyan, Reem F, Guo, Yong, Parisi, Joseph E, Lennon, Vanda A, Lucchinetti, Claudia F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893459/
https://www.ncbi.nlm.nih.gov/pubmed/24252214
http://dx.doi.org/10.1186/2051-5960-1-40
_version_ 1782299692920471552
author Popescu, Bogdan F Gh
Bunyan, Reem F
Guo, Yong
Parisi, Joseph E
Lennon, Vanda A
Lucchinetti, Claudia F
author_facet Popescu, Bogdan F Gh
Bunyan, Reem F
Guo, Yong
Parisi, Joseph E
Lennon, Vanda A
Lucchinetti, Claudia F
author_sort Popescu, Bogdan F Gh
collection PubMed
description BACKGROUND: Central pontine myelinolysis (CPM) is a demyelinating disorder of the central basis pontis that is often associated with osmotic stress. The aquaporin water channels (AQPs) have been pathogenically implicated because serum osmolarity changes redistribute water and osmolytes among various central nervous system compartments. RESULTS: We characterized the immunoreactivity of aquaporin-1 and aquaporin-4 (AQP1 and AQP4) and associated neuropathology in microscopic transverse sections from archival autopsied pontine tissue from 6 patients with pathologically confirmed CPM. Loss of both AQP1 and AQP4 was evident within demyelinating lesions in four of the six cases, despite the presence of glial fibrillary acidic protein (GFAP)-positive astrocytes. Lesional astrocytes were small, and exhibited fewer and shorter processes than perilesional astrocytes. In two of the six cases, astrocytes within demyelinating lesions exhibited increased AQP1 and AQP4 immunoreactivities, and gemistocytes and mitotic astrocytes were numerous. Blinded review of medical records revealed that all four cases lacking lesional AQP1 and AQP4 immunoreactivities were male, whereas the two cases with enhanced lesional AQP1 and AQP4 immunoreactivities were female. CONCLUSIONS: This report is the first to establish astrocytic AQP loss in a subset of human CPM cases and suggests AQP1 and AQP4 may be involved in the pathogenesis of CPM. Further studies are required to determine whether the loss of AQP1 and AQP4 is restricted to male CPM patients, or rather may be a feature associated with specific underlying precipitants of CPM that may be more common among men. Non-rodent experimental models are needed to better clarify the complex and dynamic mechanisms involved in the regulation of AQPs in CPM, in order to determine whether it occurs secondary to the destructive disease process, or represents a compensatory mechanism protecting the astrocyte against apoptosis.
format Online
Article
Text
id pubmed-3893459
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38934592014-01-17 Evidence of aquaporin involvement in human central pontine myelinolysis Popescu, Bogdan F Gh Bunyan, Reem F Guo, Yong Parisi, Joseph E Lennon, Vanda A Lucchinetti, Claudia F Acta Neuropathol Commun Research BACKGROUND: Central pontine myelinolysis (CPM) is a demyelinating disorder of the central basis pontis that is often associated with osmotic stress. The aquaporin water channels (AQPs) have been pathogenically implicated because serum osmolarity changes redistribute water and osmolytes among various central nervous system compartments. RESULTS: We characterized the immunoreactivity of aquaporin-1 and aquaporin-4 (AQP1 and AQP4) and associated neuropathology in microscopic transverse sections from archival autopsied pontine tissue from 6 patients with pathologically confirmed CPM. Loss of both AQP1 and AQP4 was evident within demyelinating lesions in four of the six cases, despite the presence of glial fibrillary acidic protein (GFAP)-positive astrocytes. Lesional astrocytes were small, and exhibited fewer and shorter processes than perilesional astrocytes. In two of the six cases, astrocytes within demyelinating lesions exhibited increased AQP1 and AQP4 immunoreactivities, and gemistocytes and mitotic astrocytes were numerous. Blinded review of medical records revealed that all four cases lacking lesional AQP1 and AQP4 immunoreactivities were male, whereas the two cases with enhanced lesional AQP1 and AQP4 immunoreactivities were female. CONCLUSIONS: This report is the first to establish astrocytic AQP loss in a subset of human CPM cases and suggests AQP1 and AQP4 may be involved in the pathogenesis of CPM. Further studies are required to determine whether the loss of AQP1 and AQP4 is restricted to male CPM patients, or rather may be a feature associated with specific underlying precipitants of CPM that may be more common among men. Non-rodent experimental models are needed to better clarify the complex and dynamic mechanisms involved in the regulation of AQPs in CPM, in order to determine whether it occurs secondary to the destructive disease process, or represents a compensatory mechanism protecting the astrocyte against apoptosis. BioMed Central 2013-07-25 /pmc/articles/PMC3893459/ /pubmed/24252214 http://dx.doi.org/10.1186/2051-5960-1-40 Text en Copyright © 2013 Popescu et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Popescu, Bogdan F Gh
Bunyan, Reem F
Guo, Yong
Parisi, Joseph E
Lennon, Vanda A
Lucchinetti, Claudia F
Evidence of aquaporin involvement in human central pontine myelinolysis
title Evidence of aquaporin involvement in human central pontine myelinolysis
title_full Evidence of aquaporin involvement in human central pontine myelinolysis
title_fullStr Evidence of aquaporin involvement in human central pontine myelinolysis
title_full_unstemmed Evidence of aquaporin involvement in human central pontine myelinolysis
title_short Evidence of aquaporin involvement in human central pontine myelinolysis
title_sort evidence of aquaporin involvement in human central pontine myelinolysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3893459/
https://www.ncbi.nlm.nih.gov/pubmed/24252214
http://dx.doi.org/10.1186/2051-5960-1-40
work_keys_str_mv AT popescubogdanfgh evidenceofaquaporininvolvementinhumancentralpontinemyelinolysis
AT bunyanreemf evidenceofaquaporininvolvementinhumancentralpontinemyelinolysis
AT guoyong evidenceofaquaporininvolvementinhumancentralpontinemyelinolysis
AT parisijosephe evidenceofaquaporininvolvementinhumancentralpontinemyelinolysis
AT lennonvandaa evidenceofaquaporininvolvementinhumancentralpontinemyelinolysis
AT lucchinetticlaudiaf evidenceofaquaporininvolvementinhumancentralpontinemyelinolysis